Donnatal is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Phenobarbital; Hyoscyamine Sulfate; Atropine Sulfate; Scopolamine Hydrobromide.
| Product ID | 59212-425_168515f9-39ac-4726-8e52-5f20c8c0d090 |
| NDC | 59212-425 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Donnatal |
| Generic Name | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1980-12-30 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Substance Name | PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE |
| Active Ingredient Strength | 16 mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1980-12-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1980-12-30 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1980-12-30 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1980-12-30 |
| Marketing End Date | 2019-07-22 |
| Ingredient | Strength |
|---|---|
| PHENOBARBITAL | 16.2 mg/1 |
| SPL SET ID: | c93cccdc-2f92-4cb3-9d14-06acdd51d94c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |